Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Sex, Drugs, MVD, rSS and STEMI
Author(s): Sonya Burgess , Craig P Juergens , Wesley Yang , et al Added: 2 years ago

Vascular Disease and Surgery

MI/ACS
Michael G Kirby
Research Area(s) / Expertise: Job title: Visiting Professor to the Faculty of Health and Human Sciences
Professor Michael Kirby worked as a general practitioner in Letchworth, Hertfordshire 1973-2007. He was Director of HertNet (The Hertfordshire Primary Care Research Network) 1998-2007. The practice provided an open access echocardiography service for patients with heart failure for the North Hertfordshire Primary Care Trust. He was Visiting Professor to the Faculty of Health and Human Sciences,… View more
Avirup Guha
Research Area(s) / Expertise: Job title: Director of Cardio-Oncology
DrAvirup Guha, Assistant Professor at Augusta University, leads Cardio-Oncology at the Medical College of Georgia, Augusta, US. Dr Guha's ongoing research, under the patronage of the American Heart Association and the Department of Defense, delves deep into the translational science concerning biological disparities between White and Black men with prostate cancer (PC) undergoing androgen… View more
Kathleen Zhang
Research Area(s) / Expertise:

Cardio-oncology

 Job title: Assistant Professor, Department of Internal Medicine, UT Southwestern Medical Center, Fort Worth, US
Dr Kathleen Zhang works as an assistant professor in the UT Southwestern Medical Center's department of internal medicine. She is an expert in cardio-oncology, the treatment of cancer patients' cardiovascular systems.Dr Zhang obtained her medical degree from the University of Pennsylvania, where she also completed her residency in internal medicine. Her specialized training in cardiology and… View more
ERA 23: REVEAL-CKD: Underdiagnosis of CKD
Author(s): Navdeep Tangri Added: 1 year ago
ERA 23 - In this short video from ERA 23, we are joined by Dr Navdeep Tangri (Max Rady College of Medicine, Manitoba, CA) to discuss the findings from the REVEAL-CKD Trial. REVEAL-CKD is a retrospective, multinational, non-interventional, observational study which aimed to investigate the prevalence and consequences of undiagnosed chronic kidney disease (CKD) in a cohort of 670000 participants. … View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
HFA 23: Diagnosis in Heart Failure in Women
Author(s): John GF Cleland Added: 1 year ago
ESC-HFA 2023 – Prof John Cleland (University of Glasgow, Glasgow, UK) discusses the findings from a study that looked at the diagnostic of heart failure in a cohort of 1.1 million people using the NHS EMR database. Finding presented at Heart Failure 2023, showed that more people treated with LD than receive diagnosis of heart failure, this disparity was greater in women compared to men. … View more

Demographic

Heart Failure
Gaps in Modern Heart Failure and Chronic Kidney Disease Research
Author(s): Simran Singh Parmar , Vasantha Muthuppalaniappan , Debasish Banerjee Added: 1 year ago

Heart Failure

Cardiovascular Renal Metabolic
ESC 23: MULTISTARS AMI Trial
Author(s): Barbara Stähli Added: 1 year ago
ESC 2023 — Prof Barbara Stähli (University Hospital Zurich, CH) joins us onsite at ESC 23 to outline the findings of the MULTISTARS AMI Trial (NCT03135275). MULTISTARS AMI aimed to compare the safety and efficacy of two treatment strategies currently performed in clinical practice, immediate complete revascularization versus staged complete revascularization in patients presenting with ST… View more

MI/ACS

Intervention
Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease
Author(s): Daciana Dascalu Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors
Author(s): Christina Magnussen Added: 2 weeks ago
ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global… View more

Demographic

Prevention & Chronic Conditions